FDA-AstraZeneca Hearing April 8, 2009 Posted in Psych Drugs, Medical Safety Issues and tagged FDA, Bi-Polar, Advisory Committee, Risperdal, FORBES, Zyprexa, New England Journal of Medicine, Abilify, Seroquel, diabetes, schizophrenia